PATH

As countries prepare for the Global Fund Grant Cycle 8, now is the time to explore what works and how to scale it.

Tomorrow, join INPUD, Unitaid, PATH, and partners for a discussion on how harm reduction innovations can strengthen HIV and hepatitis C prevention and expand access to care for people who use drugs.

PATH’s Dr. Kimberly Green will share lessons from introducing long-acting depot buprenorphine across eight countries, including its potential to improve treatment, quality of life, and program efficiency.

This webinar will also explore:
✔️ Community-led research and responses
✔️ Simplified hepatitis C models of care
✔️ Low dead-space needles and syringes
✔️ Financing and scale-up opportunities under Global Fund Grant Cycle 8

📅 June 17, 2026
⏰ 12:00–14:00 CEST

🔗Register here: https://us06web.zoom.us/meeting/register/U2waLKILS6e1dW24SAwnbQ?_x_zm_rtaid=3aV9VBWUTlOVAOjjBuu9Jw.1781253310828.2a64d6d7fbf8e17c6b3c9970ff0c27f9&_x_zm_rhtaid=700 #/registration

Ebola outbreaks are placing renewed pressure on fragile health systems, highlighting the need for coordinated response and sustained investment in preparedness.

A new L'Espresso article explores the evolving public health landscape as the World Health Organization (WHO) responds to an Ebola outbreak, alongside broader concerns around global health funding and pandemic preparedness.

In the article, PATH’s Chief Scientific Officer Melanie Saville underscores the importance of strong systems and coordination in outbreak response.

Read more: https://bit.ly/3RMpfcS